EUVIMEDEUVIMED entdecken
EditorialOpen Access · CC BY-NC 4.0

Glomerular diseases post-hematopoietic stem cell transplantation: pathologic spectrum and plausible mechanisms

Tiffany N Caza, Kenar D Jhaveri iD

Clinical Kidney Journal · 31.05.2023 · 16 (6) · 896-900

DOI: 10.1093/ckj/sfad023 ↗

Kurz gefasst

Editorial in der Zeitschrift Clinical Kidney Journal, online erschienen am 06.02.2023. Verfasst von Tiffany N Caza und 1 weiteren Autor:innen. Beteiligte Einrichtung: Arkana Laboratories, 10810 Executive Center Drive #100, Little Rock, AR, USA. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glomerular disease is an important complication in patients undergoing hematopoietic stem cell transplantation (HSCT), impacting approximately 1%–2% of all HSCT recipients and equating to 700–1400 cases per year worldwide. Development of kidney disease in HSCT recipients is often multifactorial and a kidney biopsy is required to identify the underlying disease etiology and pathology. While glomerular disease is an important toxicity following HSCT, there are few kidney biopsy studies examining this complication, with the majority being limited to small series and case reports. A range of glomerular diseases may occur in association with HSCT. The study by Yap et al. defines this disease spectrum, which includes (in descending order) thrombotic microangiopathy (38.7%), membranous nephropathy (25.8%), mesangial proliferative glomerulonephritis (12.9%), minimal change disease (9.7%), focal segmental glomerulosclerosis (9.7%) and membranoproliferative glomerulonephritis (3.2%). In this editorial, we summarize the study and prior studies looking at glomerular diseases associated with HSCT.

Schlagwörter

Stichwörter der Autor:innen

glomerular diseasegraft-versus-host diseasehematopoietic stem cell transplantation

Autor:innen und Institutionen

  • Arkana Laboratories, 10810 Executive Center Drive #100, Little Rock, AR, USA.
  • Division of Kidney Diseases and Hypertension at Hofstra/Northwell and the Glomerular Center at Northwell Health, Lake Success, NY, USA.

ORCID-Profile: Kenar D Jhaveri

Zitieren

APA

Caza, T. N., & Jhaveri, K. D. (2023). Glomerular diseases post-hematopoietic stem cell transplantation: pathologic spectrum and plausible mechanisms. Clinical Kidney Journal, 16(6), 896-900. https://doi.org/10.1093/ckj/sfad023

Vancouver

Caza TN, Jhaveri KD. Glomerular diseases post-hematopoietic stem cell transplantation: pathologic spectrum and plausible mechanisms. Clinical Kidney Journal. 2023;16(6):896-900. doi:10.1093/ckj/sfad023

BibTeX
@article{Caza2023,
  author = {Caza, Tiffany N and Jhaveri, Kenar D},
  title = {Glomerular diseases post-hematopoietic stem cell transplantation: pathologic spectrum and plausible mechanisms},
  journal = {Clinical Kidney Journal},
  year = {2023},
  volume = {16},
  number = {6},
  pages = {896--900},
  doi = {10.1093/ckj/sfad023}
}
Kostenlos starten →